Abstract
We report the case of an acromegalic woman, aged 35 years, with a huge GH-secreting tumor, repeatedly treated with neurosurgery and radiotherapy, not responsive to bromocriptine (Br) and octreotide (SMS), whose clinical picture evolved to coma due to endocranic hypertension. Since remnant size was too large to be further treated by surgery, chemotherapy with doxorubicine (DOX) (100 mg iv every three weeks up to 0.5 mg/m2 over 7 months) was started. Treatment was followed by a rapid improvement of clinical picture with resumption out of coma, progressive decline of GH levels (from 800 ng/ml to 15 ng/ml) and a slight shrinkage of tumor. No side effects were observed during DOX administration. We suggest that in those few acromegalic patients resistant both to SMS and Br, and with poor prognosis, DOX may be effectively used.
Similar content being viewed by others
References
Melmed S. Acromegaly. N. Engl. J. Med. 322: 966, 1990.
Calabresi P., Parks R. Jr. Antiproliferative agents and drugs used for immunosuppression. In: Goodman and Gilman’s (Eds.), The pharmacological basis of therapeutics. McMillan, New York, 1980, p. 1257.
Kasperlik-Zaluska A.A., Wislawski J., Kaniewska J., Zborzil J., Frankiewicz E., Zgliczynski S. Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumor. Acta Endocrinol. (Copenh.) 116: 347, 1987.
Harris P.E., Bouloux P.M.G., Wass J.A.H., Besser G.M. Successful treatment by chemotherapy for acromegaly associated with ectopic growth hormone releasing hormone secretion from a carcinoid tumour. Clin. Endocrinol. (Oxf.) 32: 315, 1990.
Le Frak E.A., Pitha J., Rosenheim S., Gottlieb J.A. A clinicopathologic analysis for adriamycin cardiotoxicity. Cancer 32: 302, 1973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Attanasio, R., Orlandi, P., Dallabonzana, D. et al. Doxorubicine for acromegaly: a case report. J Endocrinol Invest 14, 493–497 (1991). https://doi.org/10.1007/BF03346849
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346849